These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Emerging pathways in genetic Parkinson's disease: tangles, Lewy bodies and LRRK2. Devine MJ; Lewis PA FEBS J; 2008 Dec; 275(23):5748-57. PubMed ID: 19021752 [TBL] [Abstract][Full Text] [Related]
7. Nrf2 mitigates LRRK2- and α-synuclein-induced neurodegeneration by modulating proteostasis. Skibinski G; Hwang V; Ando DM; Daub A; Lee AK; Ravisankar A; Modan S; Finucane MM; Shaby BA; Finkbeiner S Proc Natl Acad Sci U S A; 2017 Jan; 114(5):1165-1170. PubMed ID: 28028237 [TBL] [Abstract][Full Text] [Related]
8. Fibrillization of alpha-synuclein and tau in familial Parkinson's disease caused by the A53T alpha-synuclein mutation. Kotzbauer PT; Giasson BI; Kravitz AV; Golbe LI; Mark MH; Trojanowski JQ; Lee VM Exp Neurol; 2004 Jun; 187(2):279-88. PubMed ID: 15144854 [TBL] [Abstract][Full Text] [Related]
9. Gene dosage and pathogenesis of Parkinson's disease. Eriksen JL; Przedborski S; Petrucelli L Trends Mol Med; 2005 Mar; 11(3):91-6. PubMed ID: 15760766 [TBL] [Abstract][Full Text] [Related]
10. Parkin and alpha-synuclein: opponent actions in the pathogenesis of Parkinson's disease. Baptista MJ; Cookson MR; Miller DW Neuroscientist; 2004 Feb; 10(1):63-72. PubMed ID: 14987449 [TBL] [Abstract][Full Text] [Related]
11. Clinical genetics of Parkinson's disease and related disorders. Wider C; Wszolek ZK Parkinsonism Relat Disord; 2007; 13 Suppl 3():S229-32. PubMed ID: 18267241 [TBL] [Abstract][Full Text] [Related]
12. alpha-Synuclein regulation of the dopaminergic transporter: a possible role in the pathogenesis of Parkinson's disease. Sidhu A; Wersinger C; Vernier P FEBS Lett; 2004 May; 565(1-3):1-5. PubMed ID: 15135042 [TBL] [Abstract][Full Text] [Related]
13. Autosomal dominant Parkinson's disease and the route to new therapies. Morris HR Expert Rev Neurother; 2007 Jun; 7(6):649-56. PubMed ID: 17563248 [TBL] [Abstract][Full Text] [Related]
14. Involvement of alpha-synuclein in Parkinson's disease and other neurodegenerative disorders. Krüger R; Müller T; Riess O J Neural Transm (Vienna); 2000; 107(1):31-40. PubMed ID: 10809401 [TBL] [Abstract][Full Text] [Related]
15. Impact of recent genetic findings in Parkinson's disease. Klein C; Lohmann-Hedrich K Curr Opin Neurol; 2007 Aug; 20(4):453-64. PubMed ID: 17620882 [TBL] [Abstract][Full Text] [Related]
16. Neuropathology of Parkinson's disease associated with the LRRK2 Ile1371Val mutation. Giordana MT; D'Agostino C; Albani G; Mauro A; Di Fonzo A; Antonini A; Bonifati V Mov Disord; 2007 Jan; 22(2):275-8. PubMed ID: 17149743 [TBL] [Abstract][Full Text] [Related]
17. Genetics of Parkinson's disease. Bonifati V Minerva Med; 2005 Jun; 96(3):175-86. PubMed ID: 16175160 [TBL] [Abstract][Full Text] [Related]
18. Update on the genetics of Parkinson's disease. Gasser T Mov Disord; 2007 Sep; 22 Suppl 17():S343-50. PubMed ID: 18175395 [TBL] [Abstract][Full Text] [Related]
19. Reduced content of α-synuclein in peripheral blood leukocytes of patients with LRRK2-associated Parkinson's disease. Pchelina SN; Emelyanov AK; Yakimovskii AF; Miller DW; Shabalina IG; Drozdova AS; Schwarzman AL Bull Exp Biol Med; 2011 Apr; 150(6):679-81. PubMed ID: 22235415 [TBL] [Abstract][Full Text] [Related]